HighPoint Advisor Group LLC Sells 19,691 Shares of CME Group Inc. $CME

HighPoint Advisor Group LLC decreased its position in CME Group Inc. (NASDAQ:CME) by 43.1% during the 3rd quarter, Holdings Channel.com reports. The firm owned 26,000 shares of the financial services provider’s stock after selling 19,691 shares during the period. HighPoint Advisor Group LLC’s holdings in CME Group were worth $7,025,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors have also bought and sold shares of the company. Amundi grew its stake in shares of CME Group by 24.0% during the 2nd quarter. Amundi now owns 1,987,347 shares of the financial services provider’s stock worth $548,150,000 after acquiring an additional 385,225 shares during the period. Truist Financial Corp lifted its holdings in CME Group by 8.9% during the third quarter. Truist Financial Corp now owns 70,712 shares of the financial services provider’s stock valued at $19,106,000 after purchasing an additional 5,773 shares during the last quarter. Alley Investment Management Company LLC boosted its position in CME Group by 86.0% during the third quarter. Alley Investment Management Company LLC now owns 29,223 shares of the financial services provider’s stock worth $7,896,000 after purchasing an additional 13,512 shares during the period. Elevate Capital Advisors LLC boosted its position in CME Group by 85.2% during the third quarter. Elevate Capital Advisors LLC now owns 8,519 shares of the financial services provider’s stock worth $2,302,000 after purchasing an additional 3,919 shares during the period. Finally, Victory Financial Group LLC increased its stake in shares of CME Group by 310.2% in the second quarter. Victory Financial Group LLC now owns 3,044 shares of the financial services provider’s stock worth $839,000 after purchasing an additional 2,302 shares in the last quarter. 87.75% of the stock is owned by hedge funds and other institutional investors.

Insider Transactions at CME Group

In other news, CEO Terrence A. Duffy sold 25,000 shares of the business’s stock in a transaction dated Thursday, December 11th. The stock was sold at an average price of $269.55, for a total transaction of $6,738,750.00. Following the completion of the transaction, the chief executive officer owned 65,804 shares of the company’s stock, valued at approximately $17,737,468.20. The trade was a 27.53% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director William R. Shepard acquired 251 shares of the firm’s stock in a transaction that occurred on Tuesday, December 30th. The stock was bought at an average price of $278.37 per share, for a total transaction of $69,870.87. Following the completion of the transaction, the director owned 258,710 shares of the company’s stock, valued at $72,017,102.70. The trade was a 0.10% increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. Company insiders own 0.30% of the company’s stock.

CME Group News Roundup

Here are the key news stories impacting CME Group this week:

• Positive Sentiment: Q4 results beat and record annual metrics — CME reported Q4 non‑GAAP EPS of $2.77 (vs. ~$2.75 est.) and revenue around $1.65B; management said 2025 produced record annual revenue and adjusted earnings. This confirms durable profitability and supports the rally. PR Newswire: CME Group Inc. Reports Fourth Consecutive Year of Record Annual Revenue…
• Positive Sentiment: Record trading volumes/ADV — January set a record 29.6M contracts (up 15% YoY) and the company reported its highest-ever ADV in several product categories, boosting fee-related revenue. Strong volumes underpin near-term revenue growth. PR Newswire: CME Group January Volume Sets New Record…
• Positive Sentiment: Guidance and product expansion — Management targets a 1%–1.5% revenue lift from fee adjustments and is expanding 24/7 crypto and securities clearing, which could open new fee pools and justify multiple expansion if uptake continues. MSN: CME Group targets 1%–1.5% revenue lift…
• Positive Sentiment: Macro/flow tailwinds — Reuters and other outlets noted higher hedging demand lifted trading activity and profit, reinforcing that market structure and client flows are supporting revenue this quarter. Reuters: Derivatives exchange CME’s profit rises as hedging demand lifts trading volume
• Neutral Sentiment: Exploring a proprietary token and tokenized cash pilot — CEO Terry Duffy said CME is studying a CME‑issued token and is piloting tokenized cash infrastructure with Google. This signals strategic optionality into tokenization but also introduces regulatory and execution uncertainty. Cointelegraph: CME CEO Duffy says exchange is exploring issuing its own token
• Neutral Sentiment: Analyst coverage and targets generally supportive — multiple firms maintain buy/overweight ratings and median price targets sit above current levels, which can prop up sentiment but are not guarantees of upside. QuiverQuant: CME Releases Q4 2025 Earnings (includes analyst notes)
• Negative Sentiment: Insider selling activity — filings show notable insider sales in recent months, which can be read as a modest negative signal for sentiment even though institutional holdings remain large. QuiverQuant: CME Releases Q4 2025 Earnings (insider transaction details)

Analysts Set New Price Targets

CME has been the topic of a number of recent research reports. TD Cowen upgraded shares of CME Group from a “hold” rating to a “buy” rating in a research note on Wednesday, January 14th. Argus lowered their target price on shares of CME Group from $308.00 to $295.00 in a report on Friday, October 31st. JPMorgan Chase & Co. raised their price target on CME Group from $256.00 to $262.00 and gave the stock an “underweight” rating in a report on Thursday, January 22nd. Weiss Ratings reiterated a “buy (b+)” rating on shares of CME Group in a research note on Monday, December 29th. Finally, Royal Bank Of Canada raised their target price on CME Group from $282.00 to $295.00 and gave the stock a “sector perform” rating in a research note on Friday, December 5th. Nine equities research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and three have issued a Sell rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus price target of $292.18.

CME Group Trading Up 0.5%

CME Group stock opened at $294.62 on Thursday. The company has a debt-to-equity ratio of 0.12, a quick ratio of 1.02 and a current ratio of 1.02. CME Group Inc. has a fifty-two week low of $239.70 and a fifty-two week high of $296.76. The stock has a market cap of $106.24 billion, a P/E ratio of 28.55, a PEG ratio of 3.30 and a beta of 0.27. The firm’s fifty day moving average price is $276.15 and its 200-day moving average price is $272.67.

CME Group (NASDAQ:CME) last posted its quarterly earnings data on Wednesday, February 4th. The financial services provider reported $2.77 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.75 by $0.02. The company had revenue of $1.65 billion during the quarter, compared to analyst estimates of $1.64 billion. CME Group had a return on equity of 14.61% and a net margin of 58.84%.The firm’s quarterly revenue was up 8.1% on a year-over-year basis. During the same quarter last year, the company earned $2.52 earnings per share. Equities research analysts forecast that CME Group Inc. will post 10.49 earnings per share for the current fiscal year.

About CME Group

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.